KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression
Despite recent progress in the identification of mediators of podocyte injury, mechanisms underlying podocyte loss remain poorly understood, and cell-specific therapy is lacking. We previously reported that kidney and brain expressed protein (KIBRA), encoded by WWC1, promotes podocyte injury in vitr...
Main Authors: | Kristin Meliambro, Yanfeng Yang, Marina de Cos, Estefania Rodriguez Ballestas, Caroline Malkin, Jonathan Haydak, John R. Lee, Fadi Salem, Laura H. Mariani, Ronald E. Gordon, John M. Basgen, Huei Hsun Wen, Jia Fu, Evren U. Azeloglu, John Cijiang He, Jenny S. Wong, Kirk N. Campbell |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical investigation
2023-04-01
|
Series: | JCI Insight |
Subjects: | |
Online Access: | https://doi.org/10.1172/jci.insight.165002 |
Similar Items
-
AMPK mediates regulation of glomerular volume and podocyte survival
by: Khadija Banu, et al.
Published: (2021-10-01) -
TYRO3 agonist as therapy for glomerular disease
by: Fang Zhong, et al.
Published: (2023-01-01) -
Age-related GSK3β overexpression drives podocyte senescence and glomerular aging
by: Yudong Fang, et al.
Published: (2022-02-01) -
Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
by: Jiafa Ren, et al.
Published: (2021-08-01) -
Accumulation of α-synuclein mediates podocyte injury in Fabry nephropathy
by: Fabian Braun, et al.
Published: (2023-06-01)